Key statistics
On Wednesday, Organon & Co (7XP:DUS) closed at 17.88, -13.83% below its 52-week high of 20.75, set on Jul 30, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 18.31 |
---|---|
High | 18.31 |
Low | 17.88 |
Bid | 17.92 |
Offer | 18.04 |
Previous close | 18.31 |
Average volume | 495.50 |
---|---|
Shares outstanding | 257.47m |
Free float | 257.05m |
P/E (TTM) | 5.29 |
Market cap | 5.29bn USD |
EPS (TTM) | 3.89 USD |
Annual div (ADY) | 1.02 EUR |
---|---|
Annual div yield (ADY) | 5.55% |
Div ex-date | Aug 16 2024 |
Div pay-date | Sep 12 2024 |
Data delayed at least 15 minutes, as of Sep 18 2024 18:30 BST.
More ▼
Press releases
- Organon to Acquire Dermavant including its Innovative Dermatologic Therapy, VTAMA® (tapinarof) Cream, 1%
- Organon & Lilly Expand Migraine Commercialization Agreement to 11 Additional Markets
- Organon Reports Results for the Second Quarter Ended June 30, 2024
- Organon To Report Second Quarter 2024 Results and Host Conference Call on August 6, 2024